Hjem › Diffust stort B-celle lymfom › Arizona › Tucson
Diffust stort B-celle lymfom kliniske forsøg i Tucson, AZ
4 studier for Diffust stort B-celle lymfom søger deltagere på steder i og omkring Tucson (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
RekruttererFase 1/2
- University of Arizona Cancer Center, Tucson
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
RekruttererFase 3
- The University of Arizona Cancer Center - North Campus ( Site 0124), Tucson
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
RekruttererFase 2
- Banner University Medical Center - Tucson, Tucson
- University of Arizona Cancer Center-North Campus, Tucson
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
RekruttererFase 2
- Banner University Medical Center - Tucson, Tucson
- University of Arizona Cancer Center-North Campus, Tucson
Diffust stort B-celle lymfom forsøg i andre byer
- New York City, NY21 studier
- Baldwin Park, CA19 studier
- Chicago, IL18 studier
- Houston, TX17 studier
- Los Angeles, CA17 studier
- Boston, MA16 studier
- Milwaukee, WI16 studier
- Nashville, TN15 studier
- Portland, OR15 studier
- Philadelphia, PA15 studier
- Durham, NC14 studier
- Dallas, TX13 studier
Andre studier i Tucson
- Brystkræft20 studier
- Ikke-småcellet lungecancer17 studier
- Overvægt17 studier
- Overvægt15 studier
- Metastatisk cancer14 studier
- Kræft (alle typer)12 studier
- Kardiovaskulær sygdom12 studier
- Colorektal kræft11 studier
- Prostatakræft11 studier
- Steatotisk leversygdom10 studier
- Hjertesvigt10 studier
- Højt blodtryk10 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.